Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros








Intervalo de año
1.
Asian Pac J Allergy Immunol ; 1993 Jun; 11(1): 5-11
Artículo en Inglés | IMSEAR | ID: sea-36554

RESUMEN

The cytokine interleukin-5 (IL-5) and the lipid mediator platelet-activating factor (PAF) have both been shown to be involved in eosinophil differentiation and activation. We have measured and compared the effect of PAF and IL-5 on human eosinophils in terms of their luminol-dependent chemiluminescence (CL) response and their expression of complement receptors, CR1 and CR3. Both IL-5 and PAF enhanced the eosinophil CL response. The optimal concentrations were 40 U/ml for IL-5, and 10(-6) M for PAF. The priming effect of IL-5 was slow and reached a maximal response after 90 minutes incubation. In contrast, the effect of PAF peaked early and declined during incubation. In the complement receptor study, only PAF was able to enhance CR3 expression (p < 0.05) while the effect of IL-5 on eosinophil complement receptor expression was negligible. These results provide evidence that both inflammatory mediator (PAF) and cytokine (IL-5) can activate eosinophils but the effects of IL-5 and PAF on eosinophil CL response appear to be distinct. The activation of eosinophils by PAF and IL-5 may occur through different mechanisms.


Asunto(s)
Asma/inmunología , Mediciones Luminiscentes , Diterpenos , Eosinófilos/inmunología , Ginkgólidos , Humanos , Interleucina-5/inmunología , Lactonas/farmacología , Luminol , Antígeno de Macrófago-1/inmunología , Fagocitosis/inmunología , Factor de Activación Plaquetaria/antagonistas & inhibidores , Receptores de Complemento/inmunología , Receptores de Complemento 3b/inmunología , Rinitis/inmunología , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA